Portfolio company
Manas AI
United Kingdom
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
The company develops AI-driven foundational models to accelerate the discovery and development of medicines for the biopharmaceutical industry.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Variartional
This company develops generative artificial intelligence to accelerate the discovery and optimization of novel small molecules for biopharmaceutical researchers and drug developers.
DreamFold
This company develops generative AI models for protein design to discover new therapeutic drugs for pharmaceutical researchers and clinicians.
Xaira
The company develops artificial intelligence platforms to design and develop antibody-based medicines for patients with various diseases.
Khumbu
This company develops artificial intelligence models for molecular biology and protein-ligand interactions to accelerate drug discovery for the pharmaceutical industry.
Drug Discovery
This company develops an artificial intelligence platform for automated molecular synthesis and drug discovery to assist pharmaceutical researchers in creating novel therapeutics.
Serna Bio
This company develops an AI-native platform to discover small molecule drugs targeting RNA for pharmaceutical partners treating respiratory and other complex diseases.
Duplicat
This company develops artificial intelligence technology to accelerate molecular discovery and enhance drug compound identification for pharmaceutical businesses.
AI-enabled drug design
This company develops generative machine learning platforms to design and optimise small-molecule drug candidates for pharmaceutical and biotechnology partners.